A 12-Week,Randomized, Semi Double-Blinded Study Evaluati

Project: Research project

Project Details

Description

IM119-014: A 12-Week, Randomized, Semi Double-Blinded Study Evaluating the Effects of Daily Oral High-Dose Atorvastatin or BMS-582949 on Atherosclerotic Plaque Inflammation as Determined by FDG-PET in High Risk Atherosclerotic Patients
StatusFinished
Effective start/end date5/12/095/31/11

Funding

  • BRISTOL-MYERS SQUIBB PHARM RES

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.